Dr Vigdorth has 30 years of drug development research experience in the clinical setting and pharmaceutical and CRO industries. She has led clinical development programs across a range of therapeutic indications with extensive experience in antibiotic, antiviral, vaccine, and antifungal agents.
Dr Vigdorth's experience has developed from multiple perspectives including working in the clinical investigative site setting, multi- national pharmaceutical company drug development, to Contract Research Organization. This experience has allowed her to have the vision to facilitate strategies for therapeutic differentiation that strengthens business opportunities in an ever increasingly competitive marketplace.
As the VP of Allergy, Respiratory, Infectious Disease and Vaccines for Quintiles, at the 12th annual World Vaccine Congress, Dr Vigdorth will address the issues of climate change in vaccine trials: Moving from a one-size-fits-all to a custom fit in operational delivery.
She will explore the critical role of epidemiology, temporal requirements and local customs integration into design, planning and delivery for successful vaccine trials.
Part of the presentation will be 4 case studies:
What are the possible challenges and how to overcome them in a global environment
- H1N1 – Timeline Compression Requires Rapid Results
- Pneumococcal – Community Outreach Country-Level Model
- Dengue/JEC – Country-Focused Continental Model
- Malaria – Preliminary Practice-based Trials Provide
All this and much more will be discussed on April 11th 2012. Get your questions ready!
Have a look at the Congress program here.
Ensure you join us at the event at the best possible ticket price by booking your place before the 27th January – register here.